News | Myeloid Therapeutics | United States

mRNA Cell Therapy

ATAK™ Monocytes

Primed Monocytes

Invivo mRNA Programming

Invivo LNP Programming

Myeloid Multi-Engagers

> Trimes

Search

Jun 3

Myeloid Therapeutics Appoints Sadettin Ozturk, Ph.D., as Chief Technology and Manufacturing Officer

Myeloid Therapeutics Appoints Sadettin Ozturk, Ph.D., as Chief Technology and Manufacturing Officer

142 views

Myeloid CEO Daniel Getts Named an Emerging Pharma Leader by Pharmaceutical Executive Magazine

May 11

Myeloid CEO Daniel Getts Named an Emerging Pharma Leader by Pharmaceutical Executive Magazine

Daniel Getts is Named an Emerging Pharma Leader by Pharaceutical Executive Magazine

186 views

May 4

Myeloid Therapeutics Appoints Leading Immunologist, Cell & Gene Therapy Expert Bruce McCreedy, Ph.D.

Myeloid Therapeutics Appoints Leading Immunologist, Cell and Gene Therapy Expert Bruce McCreedy

118 views